$2.92
0.010.34%
Last update: Nov 5, 6:42 PM
Nasus Pharma Ltd
NSRXAMEX
The average analyst price target for Nasus Pharma is $16.50, 465.1% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $7 to $22. The latest change came on Oct 30, 2026, when Maxim Group initiated coverage of Nasus Pharma with a Buy rating and a $7 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
